enVVeno Medical (NVNO) Equity Ratio (2017 - 2026)

enVVeno Medical's Equity Ratio history runs 10 years deep, the most recent figure standing at 0.91 for Q1 2026.

• In Q1 2026, Equity Ratio fell 3.61% year-over-year to 0.91; the TTM figure through Mar 2026 stood at 0.91 (down 3.61% YoY), while the FY2025 annual figure was 0.92, down 2.14% from the prior year.
• Equity Ratio was 0.91 for Q1 2026 at enVVeno Medical, down from 0.92 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.95 in Q4 2023 to a low of 0.89 in Q3 2023.
• Historically, Equity Ratio has averaged 0.93 across 5 years, with a median of 0.93 in 2022.
• The sharpest annual moves came in 2023 and 2024: Equity Ratio declined 5.53% in 2023, then gained 6.0% in 2024.
• A 5-year view of Equity Ratio shows it stood at 0.93 in 2022, then rose by 2.18% to 0.95 in 2023, then slipped by 1.27% to 0.94 in 2024, then declined by 2.14% to 0.92 in 2025, then slipped by 0.85% to 0.91 in 2026.
• The last three Equity Ratio figures came in at 0.91 (Q1 2026), 0.92 (Q4 2025), and 0.91 (Q3 2025), per Business Quant data.